Safety
Cannabis and Antidepressants in Australia — Drug Interactions Explained
Using cannabis while on antidepressants? Here's what Australian research says about SSRIs, SNRIs, TCAs, the cytochrome P450 enzyme system, and how to minimise risk when combining cannabis with antidepressant medications.
Millions of Australians take antidepressants. A growing number are also using cannabis. What happens when the two combine? The answer is more nuanced than a simple “safe” or “dangerous” — it depends on the type of antidepressant, the cannabis product, the dose, and your individual physiology.
This guide explains the known and suspected interactions, the research gaps, and what you should discuss with your doctor before combining cannabis and antidepressants.
Why drug interactions matter
Your body processes most medications through a system of liver enzymes called the CYP450 system (specifically enzymes like CYP2C19, CYP3A4 and CYP2D6). Many drugs compete for these same enzymes — when one drug blocks or slows an enzyme, it can cause another drug to accumulate to higher-than-intended levels in your blood, potentially causing toxicity or unexpected side-effects.
Both THC and CBD interact with CYP450 enzymes, which is why cannabis can alter the blood levels of many co-administered medications — including antidepressants.
Interactions by antidepressant type
SSRIs (Selective Serotonin Reuptake Inhibitors)
Examples: sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), citalopram
This is the most commonly prescribed antidepressant class in Australia. SSRIs like sertraline and citalopram are metabolised primarily by CYP2C19, an enzyme that CBD can inhibit. This means:
- CBD may increase blood levels of some SSRIs, potentially amplifying side-effects like nausea, insomnia, or sexual dysfunction
- The clinical significance in most adults appears to be low, but is more likely to matter at high CBD doses
- Both THC and SSRIs can increase serotonin activity — at very high THC doses, there is a theoretical risk of contributing to serotonin syndrome (rare but serious: agitation, rapid heart rate, tremors, fever)
Current assessment: Interactions are possible but appear low-risk in most adults at normal therapeutic doses. Monitor for amplified SSRI side-effects.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
Examples: venlafaxine (Effexor), duloxetine (Cymbalta)
Similar enzyme pathway concerns as SSRIs. Additionally, both cannabis and SNRIs can affect blood pressure — combining them may cause more pronounced blood pressure fluctuations. People on SNRIs should be particularly cautious about high-THC products.
TCAs (Tricyclic Antidepressants)
Examples: amitriptyline, nortriptyline
TCAs are metabolised by CYP2D6, which can be inhibited by CBD. This may increase TCA blood levels. TCAs also have sedative effects that cannabis (especially THC) may amplify significantly — the combination can cause excessive drowsiness, dizziness and increased fall risk.
Current assessment: More caution warranted than with SSRIs. Discuss dose adjustments with your doctor if combining.
MAOIs (Monoamine Oxidase Inhibitors)
Examples: phenelzine, tranylcypromine — rare in Australia but still prescribed
MAOIs are high-risk for interactions. They carry strict dietary restrictions and interact with many drugs. The combination of MAOIs and cannabis carries a theoretical risk of significant cardiovascular effects and heightened psychoactive reactions. Avoid combining cannabis with MAOIs without specialist medical supervision.
Bupropion (Wellbutrin/Zyban)
Bupropion lowers the seizure threshold and is metabolised through CYP2D6. Cannabis can also lower the seizure threshold at high doses. The combination warrants caution, particularly in people with a seizure history.
The Australian research picture
A 2022 real-world evidence study from Australian medical data examined patients who added medicinal cannabis to existing medication regimes. The research found that cannabis introduction was associated with reductions in some other medications over time — but also highlighted the importance of monitoring for interactions in patients taking multiple drugs.
A 2026 Monash University study raised safety concerns specifically about higher-THC products, finding that psychiatric disorders were the most commonly reported adverse reaction in 1,124 adverse event reports to the TGA. People taking antidepressants should be especially cautious about high-THC products, as THC can exacerbate anxiety and mood instability in some individuals.
The THC-anxiety paradox: important for antidepressant users
Here’s something that surprises many people: cannabis can both relieve and worsen anxiety, depending on the dose and the person.
- Low to moderate doses of THC may reduce anxiety for many users
- High doses of THC can trigger anxiety, paranoia and panic attacks — particularly in people who are anxious to begin with
- CBD, without significant THC, has consistently anti-anxiety effects in research
For people taking antidepressants — who are often managing anxiety or depression — this makes product selection especially important. CBD-dominant products carry significantly lower risk than high-THC products for this population.
What to tell your doctor
If you take antidepressants and are considering using cannabis, here’s what to bring to your appointment:
- Your current antidepressant name, dose and how long you’ve been taking it
- What you’re hoping cannabis will help with (sleep, anxiety, pain, etc.)
- The type of product you’re considering (CBD oil, edibles, flower, etc.)
- Your alcohol consumption — cannabis, alcohol and antidepressants all affect the central nervous system and the combination of all three amplifies risks
Your doctor or pharmacist can run a formal drug interaction check and advise on monitoring.
Practical harm reduction for cannabis + antidepressant users
If you do choose to combine cannabis with antidepressants:
- Start with CBD-dominant or CBD-only products — the lowest-risk option
- Avoid high-THC products, especially if you experience anxiety
- Don’t use alcohol alongside cannabis and antidepressants — all three together substantially increases sedation and cardiovascular risks
- Start with a very low dose and wait at least two hours before assessing the effect
- Monitor your mood closely in the first few weeks — keep a simple daily log
- Tell your pharmacist — they can flag potential interactions you might not be aware of
- Don’t stop your antidepressants abruptly — if you want to explore cannabis as an alternative, work with your doctor on a supervised tapering plan
The bottom line
There is currently no comprehensive evidence of severe clinical interactions between cannabis and most commonly prescribed antidepressants at typical doses. However, interactions are biologically plausible — especially with high-CBD or high-THC products — and the evidence base is still catching up with the widespread use.
The safest approach is to treat cannabis like any other medication: disclose it to your healthcare providers, start low, monitor carefully, and avoid combining it with high-risk scenarios (alcohol, MAOIs, high-THC products).
Browse our CBD topicals and edibles for lower-risk options, or explore our full range of vaporizers and flower if you’re an experienced user working with medical supervision.